How a TINA.org Reader Tip Led to a Record Penalty for False Made in USA Claims
FTC says civil penalty against Williams-Sonoma is “the largest ever in a Made in USA case.”
In January 2014, a class-action lawsuit filed against Novartis Consumer Health over its marketing and pricing of Excedrin Migraine was removed to federal court. The complaint, which was originally filed in December 2013 in California state court, alleges that the company misleadingly represents Excedrin Migraine will treat migraines more effectively, and is therefore more expensive, than Excedrin Extra Strength when both medications actually contain the same amounts of the same ingredients. (Cortina et al v. Novartis Consumer Health, Inc., Case No. 14-cv-00069, S. D. CA.).
Two other class-action lawsuits have been filed against Novartis in the last two months making the same allegations, one in New Jersey and one in New York. (Yingst et al v. Novartis AG, Novartis Corporation, and Novartis Consumer Health, Inc., Case No. 13-cv-07919, D. NJ., and Anthony et al v. Novartis AG, Novartis Corporation, and Novartis Consumer Health, Inc., Case No. 14-cv-00161, E. D. NY.)
For more information about other class-action lawsuits regarding Excedrin Migraine and TINA.org’s coverage of the product, click here.
For more information about other class-action lawsuits regarding the deceptive advertising of migraine medications, click here.
FTC says civil penalty against Williams-Sonoma is “the largest ever in a Made in USA case.”
The NBA superstar isn’t just cashing endorsement checks.
Lawsuit alleges environmental claims don’t stick.
Got milk? Apparently not.
Flag on the play.